Abiomed Announces Fiscal First Quarter Revenue of $19.9 Million and Record Impella(R) Revenue up 107% to $12 Million

DANVERS, Mass.--(BUSINESS WIRE)--Abiomed, Inc. (NASDAQ: ABMD), a leading provider of breakthrough heart support technologies, today announced first quarter of fiscal 2010 revenue of $19.9 million, up 21% compared to revenue of $16.4 million for the first quarter of fiscal 2009.